Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Sarissa Capital Management LP
Form 13F · Q2 2026

Sarissa Capital Management LP

CIK 1577524Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$178M
Reported book value
10
Positions
12
Quarters on record
Top 50
Positions

Sarissa Capital Management LP — holdings

Top 10 positions of 10, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1INVA Innoviva Inc1.9M−11.3%$43M24.1%
2IRWD Ironwood Pharmaceuticals Inc9.2M+0.0%$39M21.7%
3AMARIN CORP PLC Amarin Corp Plc1.7M+0.0%$27M15.0%
4NBIX Neurocrine Biosciences Inc116,533+0.0%$20M11.0%
5CYTK Cytokinetics Inc228,623+0.0%$19M10.9%
6LNTH Lantheus Hldgs Inc166,919+0.0%$19M10.4%
7BHVN Biohaven Ltd582,312+3.4%$9M4.9%
8REGN Regeneron Pharmaceuticals4,190+0.0%$3M1.5%
9VOR Vor Biopharma Inc25,399+0.0%$467,5960.3%
10BIIB Biogen Inc950—$205,2570.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.